Global 3-amino-2,2-dimethylpropionamide Market: Overview
3-amino-2,2-dimethylpropionamide is a versatile intermediate which is largely used in the synthesis of pharmaceuticals. It is a solid, organic compound with chemical formula C5H12N2O. It is white to off-white in color. Its boiling point is 271°C and its melting point ranges between 74°C and 82°C. 3-amino-2,2-dimethylpropionamide has density of 1.004. It is easily soluble in dimethyl sulfoxide (DMSO), an organosulfur compound with chemical formula (CH3)2SO, and methanol. It is an active pharmaceutical ingredient (API). 3-amino-2,2-dimethylpropionamide functions primarily as a building block of pharmaceuticals. It is mostly used as a reagent in the manufacture of Aliskiren, a direct renin inhibitor. 3-amino-2,2-dimethylpropionamide is listed in the United Kingdom Occupational Exposure Limits, the United Kingdom Maximum Exposure Limits, Domestic Substances List in Canada, Toxic Substances Control Act (TSCA), and the EU Derivatives.
Global 3-amino-2,2-dimethylpropionamide Market: Drivers
Increasing demand for Aliskiren in the pharmaceutical sector is fueling the market for 3-amino-2,2-dimethylpropionamide. Moreover, the demand for 3-amino-2,2-dimethylpropionamide is anticipated to increase significantly in the near future, primarily due to the rising demand for antihypertensive drugs. Aliskiren has been approved for use in the treatment of chronic kidney disease (CKD) and hypertension. There is also a possibility of Aliskiren becoming a reasonable therapeutic choice for numerous clinical conditions such as diabetes, cerebrovascular disease, cardiorenal syndrome, stable coronary artery disease, and peripheral arterial disease in the next few years. This is anticipated to increase the demand for Aliskiren in the near future, thereby driving the market for 3-amino-2,2-dimethylpropionamide. Furthermore, the pharmaceutical industry has witnessed rapid growth in the last few years. The trend is anticipated to continue throughout the forecast period, thereby propelling the demand for 3-amino-2,2-dimethylpropionamide.
Global 3-amino-2,2-dimethylpropionamide Market: Key Segments
The global 3-amino-2,2-dimethylpropionamide market can be segmented based on purity, application, and region. In terms of purity, the global 3-amino-2,2-dimethylpropionamide market can be divided into less than 99% pure and more than 99% pure. Based on application, the market can be classified into R&D, reagents for pharmaceutical drugs, and others.
Based on region, the global 3-amino-2,2-dimethylpropionamide market can be segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of consumption, North America dominated the global 3-amino-2,2-dimethylpropionamide market in 2017, closely followed by Europe and Asia Pacific. The region is anticipated to dominate the global market throughout the forecast period. This can be primarily ascribed to growth of the pharmaceutical industry in the region, particularly in the U.S. The pharmaceutical industry in North America is the largest continental pharmaceutical industry worldwide. The U.S. alone accounts for over 45% share of the global pharmaceutical industry. On the other hand, in terms of production, Asia Pacific dominates the global 3-amino-2,2-dimethylpropionamide market. The market in Asia Pacific is anticipated to be expand at a rapid pace in the next few years. The region is likely to offer substantial growth opportunities to the market in the near future. Furthermore, India, Japan, Singapore, South Korea, Australia, and countries in Southeast Asia are anticipated to offer immense growth opportunities to the 3-amino-2,2-dimethylpropionamide market in Asia Pacific during the forecast period, owing to growth of the pharmaceutical sector in these countries. The markets in Latin America and Middle East & Africa are also anticipated to expand at high growth rates in the near future.
Global 3-amino-2,2-dimethylpropionamide Market: Key Players
Key players operating in the global 3-amino-2,2-dimethylpropionamide market are BASF AG, Yangzhou Princechem Co., Ltd., Zhejiang Tianyu Pharmaceutical Co., Ltd., Hangzhou Coben Pharmaceutical Co., Ltd., Dishman USA, Inc., Clearsynth Canada INC, Jinan Finer Chemical Co., Ltd., LUNA Chemicals Co., Ltd., Ark Pharm, Inc., Shanghai Yuanye Bio-Technology Co., Ltd., BrightGene Bio-medical Technology Co., Ltd., Advanced ChemBlocks Inc., Nanjing Ange Pharmaceutical Co., Ltd., Toronto Research Chemicals Inc., and Matrix Scientific.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.